#pharmaceutical-growth

[ follow ]
#eli-lilly #glp-1 #revenue-projections #ai-drug-discovery #insmed #arikayce #mac-lung-disease #japan-market
Business
from24/7 Wall St.
14 hours ago

Eli Lilly's Path to $1 Trillion Runs Directly Through the AI Boom

Eli Lilly's GLP-1 franchises dominate the weight-loss market, projecting significant revenue growth and a potential market cap exceeding $1 trillion.
Medicine
from24/7 Wall St.
1 week ago

Insmed CEO reveals Japan patient population exceeds US market for lung disease

Japan has a larger patient population with MAC lung disease than the U.S., significantly expanding Insmed's market potential for ARIKAYCE.
[ Load more ]